Macular Degeneration Therapy
Research results from University of Kuopio, Department of Ophthalmology update understanding of macular degeneration therapy
Published in Drug Week, June 13th, 2008
A report, 'Radicicol but not geldanamycin evokes oxidative stress response and efflux protein inhibition in ARPE-19 human retinal pigment epithelial cells,' is newly published data in European Journal of Pharmacology. According to recent research published in the European Journal of Pharmacology, "Drug delivery to retinal cells has represented a major challenge for ophthalmologists for many decades. However, drug targeting to the retina is essential in therapies against retinal diseases such as age-related macular degeneration, the most common reason of blindness in the developed countries."
"Retinal cells are chronically exposed to oxidative stress that...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2008-06-13)
More Articles from Drug Week
- American Academy of Neurology
Guideline: Vertigo can be treated easily and quickly - American Academy of Neurology
Ibuprofen, aspirin, naproxen may be equally effective at reducing risk of Alzheimer's disease - Beth Israel Deaconess Medical Center
New method effective in detecting dangerous coronary plaque - Children's Hospital of Pittsburgh
Pittsburgh scientists find protein may be key to new therapies for elevated triglycerides - JAMA and Archives Journals
Prevalence of obesity among US children and teens does not increase - JAMA and Archives Journals
Therapies appear helpful in reducing risk of depression following stroke - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
